153195-01-8 Usage
General Description
The chemical compound (2-AMINO-5-ETHYL-3-THIENYL)(4-METHOXYPHENYL)METHANONE is a heterocyclic compound consisting of a thienyl and a methoxyphenyl group linked to a methanone group through an aminoethyl chain. It is a potentially useful intermediate in organic synthesis, particularly in the production of pharmaceuticals, agrochemicals, and other fine chemicals. The compound's structure suggests that it may exhibit biological activity, and further research is warranted to explore its potential applications. Additionally, its unique molecular structure may offer opportunities for developing new chemical reactions and methodologies in organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 153195-01-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,1,9 and 5 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 153195-01:
(8*1)+(7*5)+(6*3)+(5*1)+(4*9)+(3*5)+(2*0)+(1*1)=118
118 % 10 = 8
So 153195-01-8 is a valid CAS Registry Number.
InChI:InChI=1/C14H15NO2S/c1-3-11-8-12(14(15)18-11)13(16)9-4-6-10(17-2)7-5-9/h4-8H,3,15H2,1-2H3
153195-01-8Relevant articles and documents
THIOPHENE DERIVATIVES AS PPAR AGONISTS I
-
Page/Page column 61, (2010/11/26)
The invention discloses compounds of formula (I); wherein: R is a carboxylic acid or a derivative thereof; R1 is alkyl, alkenyl, alkynyl, cycloalkyl, alkoxy, alkylthio, halo or trihalomethyl; R2 is aryl, heteroaryl, arylalkyl or heteroarylalkyl; R3 is H or F; and L is a linking group comprising a chain of from 2 to 8 atoms linking R and the carbonyl group (A); and pharmaceutically acceptable derivatives thereof, useful for treating disorders mediated by peroxisome-proliferator-activated receptor (PPAR) subtype δ (PPARδ). The compounds of the invention are therefore useful in the treatment of metabolic syndrome, obesity, type-II diabetes, dyslipidemia, wound healing, inflammation, neurodegenerative disorders and multiple sclerosis.
